What amount sold does CELLULAR BIOENGINEERING INC report in Form D filings?

The latest linked filings report $2M sold across 1 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was CELLULAR BIOENGINEERING INC's most recent SEC filing?

CELLULAR BIOENGINEERING INC's most recent Form D filing was on 2014-01-27.

How many investors does CELLULAR BIOENGINEERING INC have?

The most recent Form D filing lists 2 investor(s).

CELLULAR BIOENGINEERING INC

CIK: 0001254979·Biotechnology·HONOLULU, HI·Corporation

Reported Sold

$2,000,000

Total Filings

Identified Offerings

Last Filed

Jan 27, 2014

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Jan 27, 2014Form D — New notice

Reported sold: $2,000,000 · Target: $4,000,000

Rule 506(b)·2 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

$1 - $1,000,000

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 1 identified offering

$2,000,000

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

JEFFREY WATANABE

Related Person

Appears on 1 filing

ELLARY KIM

Related Person

Appears on 1 filing

Hank C.K. Wuh

Related Person

Appears on 1 filing

George R. Ariyoshi

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Jan 27, 2014	New	$4,000,000	$2,000,000	2

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Swep Bio, Inc.

Biotechnology

Offering target: $4,999,976

Filed Oct 29, 2026